Synthesis, characterization and biodistribution of novel amine thiophene 99mTc labeled complex

Pakistan Journal of Pharmaceutical Sciences

Volumn 25, Issue 2, 2012, Pages 381-387

  Javed, Muhammad ^a   Khan, Irfan Ullah ^a   Mobeen, Saima ^b   Dar, Ume Kalsoom ^b   Hyder, Syed Waqar ^a  

^a Institute of Nuclear Medicine and Oncology INMOL   (Pakistan)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

Amine thiophene dione; Biodistribution; Brain imaging; Radiolabeling

Indexed keywords

RADIOPHARMACEUTICAL AGENT; THIOPHENE TC 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL ANALYSIS; CHROMATOGRAPHY; COMPLEX FORMATION; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; EXPERIMENTAL RABBIT; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; INSTANT THIN LAYER CHROMATOGRAPHY; ISOTOPE LABELING; NONHUMAN; PAPER CHROMATOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; ROOM TEMPERATURE;

AMINES; ANIMALS; BRAIN; HUMANS; ISOTOPE LABELING; LIGANDS; ORGANOTECHNETIUM COMPOUNDS; PROTEIN BINDING; RABBITS; RADIOPHARMACEUTICALS; THIOPHENES; TISSUE DISTRIBUTION;

EID: 84860610440     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Atkins R, Brewer G, Kokot E, Mockler GM and Sinn E (1985). Copper (II) and nickel (II) complexes of unsymmetrical tetradentate schiff base ligands. Inorg. Chem., 24: 127-134.
2. Averill DF and Broman RF (1978). Substituted salen and baen tetradentate schiff-base ligands: Synthesis, characterization, and electrochemistry of cobalt (III) complexes. Inorg. Chem., 17: 3389-3394.
3. Costes JP, Cros G, Darbieu MH and Laurent JP (1982). The non-template synthesis of novel non-symmetrical, tetradentate Schiff bases, their nickel (II) and cobalt (III) complexes. Inorg. Chim. Acta, 60: 111-114.
4. 123I]iodoamphetamine (IMP) tomography. J. Nucl. Med., 23: 196-203.
5. Holman BL and Devous MD (1992). Functional brain SPECT: The emergence of a powerful clinical method. J. Nucl. Med., 33: 1888-1904.
6. 2 schiff-base compounds. Ann. Nucl. Med. Sci., 17: 13-19.
7. Jaouen G, Top S, Vessières A and Alberto R (2000). New paradigms for synthetic pathways inspired by bioorganometallic chemistry. J. Organomet. Chem., 600: 23-36.
8. Jurisson SS and Lydon JD (1999). Potential technetium small molecule radiopharmaceuticals. Chem. Rev., 99: 2205-2218.
9. Kovacic JE (1967). The C=N stretching frequency in the infrared spectra of Schiff's base complexes, copper complexes of salicylidene anilines. Spectrochimica Acta Part A: Molecular Spectroscopy, 23: 183-187.
10. 99mTc-radiolabeled quinazolinone derivative [Qn-In]: Synthesis, evaluation and biodistribution studies in mice and rabbit. Nucl. Med. Biol., 31: 1087-1095.
11. Kung HF and Blau M (1980). Regional intracellular pH shift: A proposed new mechanism for radiopharmaceutical uptake in brain and other tissues. J. Nucl. Med,. 21: 147-152.
12. 99mTc-labeled brain perfusion imaging agents. Sem. Nucl. Med., 20: 150-158.
13. Kung HF, Ohmomo Y and Kung MP (1990). Current and future radiopharmaceuticals for brain imaging with single photon emission computed tomography. Sem. Nucl. Med., 20: 290-302.
14. Kung HF, Tramposch KM and Blau M (1983). A new brain perfusion imaging agent: [I-123]HIPDM; N,N,N′-trimethyl-N′-[2-hydroxy-3-methyl-5- iodobenzyl]-1,3-propanediamine. J. Nucl. Med., 24: 66-72.
15. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals. Chem. Rev., 99: 2235-2268.
16. Moretti JL, Caglar M and Weinmann P (1995). Cerebral perfusion imaging tracers for SPECT: Which one to choose? J. Nucl. Med., 36: 359-363.
17. Neirinckx RD, Nowotnik DP, Pickett RD and Harrison RC (1986). Development of a lipophilic Tc-99m complex useful for brain perfusion, evaluation with conventional SPECT imaging equipment, amphetamines and pH shift agents for brain imaging. In: Basic research and clinical results. Biersack and Winkler, Berlin, pp.59-70.
18. Nowotnik DP (2002). Technetium-based brain perfusion agents. Radiopharmaceutical Chemistry and Pharmacology., 91: 37-95.
19. Rolan PE (1994). Plasma protein binding displacement interactions-why are they still regarded as clinically important? Br. J. Clin. Pharmacol., 37: 125-128.
20. Tisato F and Refosco F (1988). Rhenium (V) oxo complexes with Schiff base ligands containing four or five coordination sites. X-ray molecular structure of [N,N′-3-azapentane-1,5-diylbis(salicylideneiminato)(3-)-O,O′,N, N′,N″]oxorhenium(V). J. Chem. Soc. Dalton. Trans., 3: 611-615.
21. Winchell HS, Baldwin RM and Lin TH (1980). Development of I-123-labeled amines for brain studies: Localization of I-123 Iodophenylalkyl amines in rat brain. J. Nucl. Med., 21: 940-946.